US Patent 7504214 Predicting outcome with tamoxifen in breast cancer
Patent 7504214 was granted and assigned to Biotheranostics on March, 2009 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7504214 Predicting outcome with tamoxifen in breast cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
